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Abstract
Context: The incidence of gestational diabetes mellitus (GDM) has been on the rise, driven by maternal obesity. In 
parallel, pubertal tempo has increased in the general population, driven by childhood obesity.
Objective: To evaluate the available evidence on pubertal timing of boys and girls born to mothers with GDM.
Data sources: We searched MEDLINE, EMBASE, CINAHL Plus, Cochrane library and grey literature for observational 
studies up to October 2019.
Study selection and extraction: Two reviewers independently selected studies, collected data and appraised the studies 
for risk of bias. Results were tabulated and narratively described as reported in the primary studies.
Results: Seven articles (six for girls and four for boys) were included. Study quality score was mostly moderate (ranging 
from 4 to 10 out of 11). In girls born to mothers with GDM, estimates suggest earlier timing of pubarche, thelarche and 
menarche although for each of these outcomes only one study each showed a statistically significant association. In 
boys, there was some association between maternal GDM and earlier pubarche, but inconsistency in the direction of 
shift of age at onset of genital and testicular development and first ejaculation. Only a single study analysed growth 
patterns in children of mothers with GDM, describing a 3-month advancement in the age of attainment of peak height 
velocity and a slight increase in pubertal tempo.
Conclusions: Pubertal timing may be influenced by the presence of maternal GDM, though current evidence is sparse 
and of limited quality. Prospective cohort studies should be conducted, ideally coupled with objective biochemical 
tests.
Introduction
Puberty marks an important period in the dynamics of 
childhood development characterised by fundamental 
physical, cognitive and psychological transformation. The 
attainment of adult-like secondary sexual characteristics, 
rapid growth, changes of body composition and 
achieving fertility are the main physical outcomes of 
puberty. As a consequence of the maturation of the 
hypothalamic–pituitary–gonadal axis with subsequent 
incremental, finely orchestrated gonadal sex steroid 
production, typical physical changes occur in a successive 
fashion. In girls, this usually starts with thelarche (onset 
of breast development) and pubarche (appearance of 
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pubic hair), followed by a peak growth spurt culminating 
in menarche (first menstruation) (1). In boys, testicular 
enlargement and pubarche are the first physical signs of 
puberty followed by peak growth spurt and spermarche 
(development of sperm) with the occurrence of the first 
ejaculation.
A secular trend of advancement in pubertal timing 
along with a steep decline in the age of menarche from 
17 to 13 years has been recognized between 19th and 21st 
century (1, 2, 3). Consequently, increasing numbers of 
children are diagnosed with central precocious puberty (1, 
2), defined as the onset of gonadarche before the age of 8 
years in girls and 9 years in boys, a definition based upon 
assessment of pubertal staging performed by Tanner et al. 
in a large cohort of children in the 1960s (4, 5). Compared 
to peers who mature on time or later, early developers are 
more likely to experience psychological distress and social 
isolation, potentially leading to detrimental outcomes 
such as poor academic performance, depression, substance 
abuse, eating disorder, disturbed body image and risky 
sexual behaviour (6, 7). Early pubertal timing also has 
an adverse impact on adult metabolic health including 
increased risk of diabetes and other cardio-vascular 
morbidity (6, 7, 8).
Risk factors for early puberty are considered to be 
multifactorial and may be seen as the effect of factors 
influencing the maturation of the hypothalamic GnRH 
pulse generator. These include predisposing genetic factors, 
intrauterine environment, and endocrine-disrupting 
chemicals, and, first and foremost, abundance of nutrients 
and childhood obesity (9). Similar to the trend towards 
earlier pubertal timing driven by childhood obesity, the 
incidence of gestational diabetes mellitus (GDM) driven 
by maternal obesity has also been on the rise; in some 
countries, the incidence of GDM has doubled in the last 
decade and is predicted to further increase (10), although 
changes in screening practices might have contributed to 
this rise (11).
The effect of maternal GDM on pre-pubertal health 
outcomes in the offspring has been evaluated by a limited 
number of observational studies, but evidence on the 
effect of GDM on sexual maturation and pubertal timing 
is scarce and conflicting. Due to the complexity in the 
conceptualization of pubertal timing and its clinical 
assessment and the significant heterogeneity among the 
studies exploring the relationship between maternal GDM 
and central precocious puberty, a causal relationship has 
not been clearly established yet. If confirmed, such a link 
could drive a transgenerational continuum and, thereby, 
metabolic morbidity associated with both conditions. 
Here, we have undertaken a systematic appraisal of the 
available evidence on pubertal timing in children born to 
mothers with GDM. 
Methods
Searches
We carried out a systematic literature review search initially 
in March 2019, with the search rerun in October 2019 to 
retrieve any additional studies before final synthesis of 
results. Databases included: (i) Electronic bibliographic 
databases (MEDLINE, EMBASE, CINAHL Plus, Cochrane 
library), (ii) Google Scholar™ search and experts contact 
to obtain relevant grey literature, and (iii) citations tracked 
from the screened articles to identify further relevant 
studies. The search strategy was constructed with the help 
of a medical librarian combining natural and structured 
language terms (MESH and Emtree). Terms relating 
to ‘gestational diabetes’ was combined with an ‘AND’ 
Boolean operator to ‘puberty’, ‘pubarche, ‘thelarche’, 
‘menarche’, ‘Tanner staging’, ‘spermarche’ and ‘growth’. 
A list of search terms is provided in Supplementary Table 1 
(see section on supplementary materials given at the end 
of this article).
Records identified by the searches were independently 
screened by two reviewers (A.S. and J.I.) in the order of 
title, abstract and full text of the article. Articles were 
selected when they met the inclusion and exclusion 
criteria mentioned in the pre-defined protocol registered 
on PROSPERO (CRD42019150365). In case of study 
selection disagreements, a third reviewer (K.N.) was 
consulted to reach consensus. 
Inclusion and exclusion criteria
We included observational studies – cohort, case–control 
and cross-sectional studies. Studies that considered 
multiple exposures or multiple outcomes were also 
included, if they studied the association between maternal 
GDM and pubertal timing in the offspring. Pubertal timing 
was allowed to be described by the timing of the following 
pubertal milestones according to Tanner (4, 5): in girls, 
(i) pubic hair development/pubarche (Tanner stage: 
≥PH2), (ii) breast development/thelarche (Tanner stage: 
≥B2), (iii) menarche and (iv) speed of pubertal growth as 
peak height velocity (PHV) and age at PHV; in boys, (i) 
pubic hair development/pubarche (Tanner stage: ≥PH2), 
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either or both sides), (iii) maturation of the external male 
genitalia (Tanner stage: ≥G2), (iv) spermarche and (v) 
PHV and age at PHV. 
Studies were excluded if they were case studies, case 
series or commentary articles, qualitative studies without 
quantitative data on pubertal timing, studies reporting 
pubertal staging instead of pubertal timing disregarding 
chronological age, or studies conducted on non-human 
subjects.
Data extraction and risk of bias assessment
The JBI data extraction form (12) was adapted based on 
the specifics of this review to create a template form in 
Microsoft Word® (Supplementary Table 2). The form 
mandated data on the following elements from the 
included studies: authors, study publication date, data 
source, study period, country and setting, sample size, 
GDM exposure ascertainment criteria, proportion of 
GDM exposed women who used insulin, offspring sex, 
outcome/s considered and details on analytical methods 
employed including the list of confounding variables 
considered.
An adapted version of the Newcastle–Ottawa critical 
appraisal checklist (13) was used to evaluate the risk of 
bias of each of the included studies and individual studies 
were graded as low or high risk for each of the checklist 
questions (template form is provided in Supplementary 
Table 3). Elements employed in appraising the internal 
validity of the included studies included: (i) potential 
selection bias, that is, inclusion criteria or study setting 
giving rise to systematic difference of the sampled 
cohort from the general population; (ii) objective 
GDM diagnosis and pubertal staging measurement; (iii) 
capture of and adjustment for confounding variables; 
(iv) appropriateness of statistical analysis employed to 
account for uncertainty in the true event time such as 
interval censored time-to-event analysis or modelling 
multiple longitudinal outcome records; and (v) sufficient 
follow-up period and characteristics of patients lost to 
follow-up. Representativeness of the study population 
was also discussed to assess external validity. 
Data extraction and risk of bias assessment forms 
were pilot-tested with one of the included studies at 
the protocol-writing stage. Data extraction and quality 
appraisal were performed by two independent reviewers 
(A.S. and J.I.) and in case of disparities, a third reviewer 
(K.N.) was contacted to settle differences. 
Findings of this review are reported in accordance 
with PRISMA guidelines (Supplementary Table 4) (11).
Results
Literature search results
We identified 305 studies through electronic database 
searches, including 57 duplicates (Fig. 1). Of the remaining 
248, 230 were not relevant to the research question and 
were excluded on the basis of title and abstract, leaving 
18 studies for full-text assessment. Eleven articles were 
excluded at this stage: four articles were conference 
proceedings, oral presentations or commentary articles 
(14, 15, 16, 17); two articles did not include any of the 
outcomes we were interested in (18, 19); one article did 
not analyse GDM as a predictor for pubertal timing due 
to an insufficient number of subjects with GDM (20); two 
articles did not provide a comparator cohort (21, 22); two 
articles only reported Tanner stage at baseline and did 
not consider age/timing of puberty (23, 24). The seven 
remaining studies were included in the review (Fig. 1). 
Study characteristics
The seven primary studies included in this review (25, 
26, 27, 28, 29, 30, 31) are described in Table 1. Four 
studies were conducted in the USA (25, 27, 28, 29), 
two in Denmark (26, 30) and one in England (31). The 
populations studied were predominantly Caucasian. Four 
studies had comparable primary objectives to our review 
question (27, 28, 29, 30) two studies looked at multiple 
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at multiple developmental outcomes in the offspring of 
mothers with GDM including pubertal timing (26).
Three of the included studies focussed only on the 
pubertal timing in girls (25, 28, 29), one study focussed 
only on the pubertal timing in boys (31) and three studies 
reported outcomes for both boys and girls (26, 27, 30). All 
of the studies stratified their estimates by offspring sex.
Two pairs of the included articles derived their study 
sample from the same pregnancy cohorts and thus had the 
potential for overlapping populations (Danish National 
Birth Cohort (DNBC) (26, 30) and Kaiser Permanante 
Northern California (KPNC) (28, 29)). 
Sample size ranged widely both between and within 
studies when considering multiple outcomes (Table 
1): D’Aloissio et  al. included 33 501 daughters with 
information on age at menarche; 178 of them self-reported 
positive maternal GDM status through telephone contact 
with their mothers (25). Grunnet et al. considered multiple 
outcomes: breast and pubic hair development in 494 and 
458 girls, respectively, and testicular volume, pubic hair, 
and genital developmental stage in 374, 409 and 369 
boys, respectively (26). Hockett et  al. included 208 girls 
and 209 boys with anthropometric records to calculate 
peak height velocity; 34 girls and 43 boys had positive 
maternal GDM status (27). Two studies that used the same 
cohort (KPNC) and considered the same outcomes varied 
with regard to the maternal sample size (417 and 12 341) 
(28, 29). Lauridsen et al. included 122 and 130 girls and 
boys with positive maternal GDM exposure status (30), 
while Monteilh et  al. included 450 boys with positive 
maternal GDM exposure status (31).
Risk of bias assessment
The risk of bias based on the review question-adapted 
Newcastle Ottawa critical appraisal checklist is summarized 
for the seven included studies in Fig. 2. All populations 
studied were reasonably representative of their respective 
country’s general practice or hospital setting except for the 
study by D’Aloisio et al. (25), who had restricted inclusion 
to pregnant women at risk of breast cancer. Exposure 
information regarding GDM status was obtained from 
pregnancy registries in five studies (26, 27, 28, 29, 30), 
two of those studies also considered self-reports (26, 30). 
However, for the remaining two studies (25, 31), GDM 
status was only self-reported, indicating high risk of recall 
or misclassification bias. Studies based on KPNC cohorts 
mentioned using Carpenter and Coustan thresholds for 
GDM diagnosis. Variation was observed in the covariates 
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representing the most popular confounders considered 
in the association between maternal GDM and pubertal 
timing in the offspring. 
Outcome measurements were performed by research 
staff in four studies (26, 27, 28, 29); three of them specifically 
reported utilization of recommended methods to measure 
outcomes, such as orchidometer use for the assessment 
of testicular size, breast palpation for accurate assessment 
of the stage of breast development, and computational 
modelling (Superimposition by Translation And Rotation 
(SITAR)) of longitudinal height measurements for PHV 
and age at PHV (27, 28, 29). Outcomes were recorded 
only during a series of pre-defined observation times 
prohibiting the capture of precise pubertal timing, but 
four studies performed interval censoring to account for 
this in their analysis (28, 29, 30, 31). Notably, two studies 
recorded Tanner stage in less than 80% of the offspring 
(30, 31), suggesting a possibility of dropout bias.
Association between maternal gestational 
diabetes and pubertal timing in girls
Results of the primary studies reviewing the association 
between maternal GDM and pubertal onset in girls, as 
indicated by age at menarche, pubarche and thelarche, 
are given in Table 2.
Pubic hair development/pubarche
There was an inconsistent association between maternal 
GDM and pubarche in girls based on the four primary 
articles that studied this association. Lauridsen et al. (30) 
reported an earlier age at attainment of all pubic hair 
stages in girls of mothers with GDM ranging between 1.6 
and 6.0 months after adjustment (adjusted mean monthly 
difference in PH2: −4.8 (95% CI: −7.7, −2.0); PH3: −2.2 
(95% CI: −4.4, 0); PH4: −1.6 (95% CI: −4.8, 1.6); PH5: 
−6.0 (95% CI: −10.8, −1.2)) (Table 2). Three studies 
considered pubertal Tanner stages of ≥PH2 as an outcome 
(26, 28, 29). Grunnet et al. (26) reported an increase of 
51% in age adjusted odds for reaching ≥PH2 in girls born 
to mothers with GDM (adjusted OR: 1.51 (95% CI: 0.90, 
2.55)) (Table 2). Kubo et al. conducted two studies in 2016 
(28) and 2018 (29) using datasets derived from the same 
database assessing the hazard ratio to reach ≥PH2 for girls 
of mothers with GDM compared to controls (2015 study 
adjusted HR: 1.04 (95% CI: 0.92, 1.17) and 2018 study 
adjusted HR: 1.24 (95% CI: 0.79, 1.94)) (Table 2). When 
accounting for interaction between maternal pregravid 
BMI and GDM, there was a 3-fold increased hazard of 
Tanner stage ≥PH2 among girls born to mothers with 
GDM and a pregravid BMI ≥25 compared to mothers 
without GDM and a pregravid BMI <25 (adjusted HR: 2.97 
(95% CI: 1.52, 5.83)).
Breast development/thelarche
The same four studies that studied the association 
between pubarche and maternal GDM also studied the 
association between breast development and GDM (26, 
28, 29, 30). Lauridsen et al. (30) reported the mean age 
at Tanner breast stages 2–5 in girls born to mothers with 
and without GDM. The direction of effect size suggest 
a lower age for all Tanner stages among girls born to 
mothers with GDM (adjusted mean monthly difference 
in B2: −4.6 (95% CI: −10.1, 1.0); B3: −1.9 (95% CI: −5.0, 
1.2); B4: −0.5 (95% CI: −3.2, 2.4); B5: −1.8 (95% CI: 
−7.9, 4.3)) (Table 2). Grunnet et  al. (26) showed twice 
the age adjusted odds of ≥B2 among girls born to GDM 
mothers compared to controls (age adjusted OR: 1.99 
(95% CI: 1.18, 3.34)) (Table 2); however, once adjusted 
for offspring BMI, the significance in this association was 
no longer evident. The association between maternal 
GDM and offspring age at thelarche in the 2015 and 
2018 studies conducted by Kubo et al. was not evident 
(adjusted HR: 0.85 (0.54–1.35) and 1.06 (0.95–1.18), 
respectively) (28, 29) (Table 2).
Figure 2
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Table 2 Evidence summary of the relationship between maternal GDM and pubertal development in their daughters identified 
by pubic hair development (n = 4 studies), breast development (n = 4), peak height velocity (n = 1), menarche (n = 2) and other 
pubertal changes (n = 1).
Outcome/study Outcome metrics Estimates
Pubic hair development/pubarche
 (27) n (%) of ≥ Tanner PH2 in GDM and controls
Age adjusted OR (95% CI) of ≥ Tanner PH2
GDM: 99 (44.8%); Controls: 133 (56.1%);
OR, adjusted: 1.51 (0.90, 2.55); P = 0.12
 (30) Adjusted (for race/ethnicity, maternal age,  
education, parity, smoking during pregnancy  
and BMI) HR (95% CI) of ≥ Tanner PH2 
HR adjusted: 1.04 (0.92, 1.17)
 (31) Mean age at Tanner PH2, PH3, PH4, PH5 in  
daughters of mothers without diabetes
Mean Age (years): PH2: 11.3;  
PH3: 12.5; PH4: 13.4; PH5: 15.3
Crude and adjusted (for maternal age at menarche,  
maternal age at birth, socioeconomic status, 
cohabitation, parity and maternal BMI) mean  
monthly difference in age (95% CI) at Tanner  
PH2, PH3, PH4, PH5 
Mean difference (months):
PH2: crude: −5.4; adjusted: −4.8 (−7.7, −2.0);
PH3: crude: −3.1; adjusted: −2.2 (−4.4, 0);
PH4: crude: −2.6; adjusted: −1.6 (−4.8, 1.6);
PH5:crude: −7.8; adjusted: −6.0 (−10.8, −1.2);
 (29) Unadjusted and adjusted (for race/ethnicity,  
household income and maternal age) hazard  
ratio (95% CI) of ≥ Tanner PH2 
HR: crude: 1.09 (0.71, 1.70); adjusted: 1.24 (0.79, 1.94)
Similar estimates for the interaction between  
maternal pregravid BMI and GDM:
HR, adjusted:
BMI < 25 and no GDM: Reference category;
BMI < 25and GDM: 1.06 (0.48, 2.36);
BMI ≥ 25 and no GDM: 1.19 (0.90, 1.56);
BMI ≥ 25 and GDM: 2.97 (1.52, 5.83)
Breast Development/Thelarche
 (27) n (%) ≥ Tanner B2 in GDM cases and controls GDM: 141 (59.2%); controls: 169 (66.0%)
Age adjusted OR (95% CI) of ≥ Tanner B2 OR adjusted: 1.99 (1.18, 3.34); P = 0.01
Estimate with additional adjustment for BMI shown 
in primary study’s figure (direction of effect 
remains but statistically NS)
 (30) Adjusted (for race/ethnicity, maternal age,  
education, parity, smoking during pregnancy  
and BMI) hazard ratio (95% CI) of ≥ Tanner B2
HR adjusted: 1.06 (0.95, 1.18)
 (31) Mean age at Tanner stage B2, B3, B4, B5 in  
daughters of mothers without diabetes
Mean age (years): B2: 9.9; B3: 11.6; B4: 13.0; B5: 15.7 
Crude and adjusted (for maternal age at menarche,  
maternal age at birth, socioeconomic status, 
cohabitation, parity and maternal BMI) mean  
monthly difference in age (95% CI) at Tanner  
stage B2, B3, B4, B5
Mean difference (months):
B2: crude: −7.3; adjusted: −4.6 (-10.1, 1.0);
B3: crude: −3.8; adjusted: −1.9 (−5.0, 1.2)
B4: crude: −2.1; adjusted: −0.5 (−3.2, 2.4)
B5: crude: −4.3; adjusted: −1.8 (−7.9, 4.3)
 (29) Unadjusted and adjusted (for race/ethnicity,  
household income and maternal age) hazard  
ratio (95% CI) of breast development stage ≥ B2 
HR: crude: 1.01 (0.65, 1.57); adjusted: 0.85 (0.54, 1.35)
Similar estimates for pregravid BMI # GDM  
interaction
HR adjusted:
BMI < 25#No GDM: Reference category;
BMI < 25#GDM: 1.22 (0.54, 2.74);
BMI ≥ 25#No GDM: 1.18 (0.88, 1.57);
BMI ≥ 25#GDM: 0.93 (0.47, 1.85)
PHV and age at PHV
 (28) Age at PHV stratified by maternal GDM  
exposure status and beta coefficient for  
exposure to GDM in utero after adjusting  
for child’s race/ethnicity 
Age at PHV (years): GDM: 10.85; No GDM: 11.12
β coefficient and P-value not reported (but figure 
shows overlapping confidence intervals of age at 
PHV between exposed and the unexposed)
PHV among exposed and unexposed girls and  
boys and beta coefficient for exposure to GDM  
in utero after adjusting for child’s race/ethnicity
PHV (cm/year): GDM: 8.88; No GDM: 8.04; β 
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Age at peak height velocity
Hockett et  al. (27) examined the association between 
maternal GDM and pubertal timing in the daughters as 
reflected by growth parameters including peak height 
velocity (PHV) and age at PHV (APHV). APHV was 10.85 
years in girls born to mothers with GDM and 11.12 years 
in girls born to mothers without GDM, with overlapping 
confidence intervals (Table 2). Using a log-logistic 
accelerated failure time model, daughters born to mothers 
with GDM had a 10% higher ethnicity-adjusted height 
velocity than girls born to mothers without GDM (Table 2).
Menarche
Maternal GDM seemed to be associated with earlier age 
at menarche but the evidence is inconsistent. D’Aloisio 
et al. (25) found that girls born to mothers without pre-
gestational or gestational diabetes had no increased risk of 
earlier (≤10 and 11 years) or later age at menarche (14 and 
≥15 years) in comparison to an arbitrary defined reference 
age of 12–13 years after adjusting for birth decade, 
ethnicity and family income (Table 2). By contrast, girls 
born to mothers with pregnancy hyperglycemia had a 
significantly higher risk of earlier menarche (≤10 years) 
(adjusted RR: 1.47 (95% CI: 1.01, 2.16)). In keeping with 
these findings, Lauridsen et  al. (30) report a significant 
earlier onset of menarche by 2.5 months in girls born 
to mothers with GDM compared to mothers without 
diabetes (adjusted mean monthly difference: −2.5 (95% 
CI: −4.9, 0)) (Table 2).
Association between maternal gestational 
diabetes and pubertal timing in boys
Results of the primary studies reviewing the association 
between maternal GDM and pubertal onset exclusively 
among boys indicated by age at spermarche, pubarche 
and genital development are shown in Table 3.
Pubic hair development (pubarche)
Three studies evaluated maternal GDM and its association 
with pubarche in their sons (33, 34, 35). Grunnet et  al. 
(26) reported 74% increase in the odds of having reached 
tanner stage ≥PH2 among boys born to mothers with 
GDM compared to those born to mothers without GDM 
after adjustment for age (adjusted OR: 1.74 (95% CI: 
0.92, 3.28)) (Table 3). Lauridsen et al. (30) reported trends 
to earlier age at public hair stages among boys born to 
mothers with GDM compared to boys born to mothers 
without GDM (adjusted mean monthly difference for PH2: 
−1.4 (95% CI: −5.3, 2.4); PH3: −1.3 (95% CI: −4.6, 1.9); 
PH4: −0.8 (95% CI: −3.4, 1.6); PH5: −1.7 (95% CI: −4.7, 
1.3)) (Table 3). Monteilh et al. (31) performed a step-wise 
inclusion of covariates based on statistical significance 
to predict age at transition into stages PH2–4. GDM was 
not included in the analysis for transition into stages PH2 
Outcome/study Outcome metrics Estimates
Menarche
 (26) RR(95% CI) of earlier or later menarche in mothers  
with GDM compared to mothers without GDM  
after adjustment for birth decade, race/ethnicity, 
childhood family income, interaction between  
birth decade and race/ethnicity
RR adjusted:
≤ 10 years: 0.98 (0.53, 1.84);
11 years: 0.99 (0.63, 1.54);
12–13 years: reference category;
14 years: 0.77 (0.48, 1.25);
≥ 15 years: 0.98 (0.60, 1.60)
 (31) Mean age at menarche in daughters of mothers 
without diabetes
Mean age (years): 13.0
Crude and adjusted (for maternal age at menarche, 
maternal age at birth, socioeconomic status, 
cohabitation, parity and maternal BMI) mean 
monthly difference in age (95% CI) at menarche
Mean difference (months): crude: −4.1;  
adjusted: −2.5 (−4.9, 0.0)
Other pubertal outcomes
 (31) Crude and adjusted (for maternal age at menarche, 
maternal age at birth, socioeconomic status, 
cohabitation, parity and maternal BMI) mean 
monthly difference in age (95% CI) at development  
of axillary hair and acne 
Mean difference (months):
AH: crude: −4.4; adjusted: −3.6 (−7.3, 0.1)
Acne: crude: −3.8; adjusted: −2.6 (−6.8, 1.6)
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Table 3 Evidence summary: The relationship between maternal GDM and pubertal development in their sons identified by 
pubic hair development (n = 3 studies), testicular development (n = 2), genital development (n = 2), peak height velocity (n = 1), 
spermearche (n = 1) and other pubertal changes (n = 1). 
Outcome/study Outcome metrics Estimates
Pubic hair development/pubarche
 (27) n (%) of ≥ Tanner stage PH2 in GDM cases  
and controls
GDM: 50 (24.3%); Controls: 60 (29.6%)
Age adjusted OR (95% CI) of ≥ Tanner stage PH2 OR adjusted: 1.74 (0.92, 3.28); P = 0.09
Estimate with additional adjustment for BMI shown 
in primary study’s figure (direction of effect 
remains and still statistically NS)
 (31) Mean age at Tanner stage PH2, PH3, PH4,  
PH5 in sons of mothers without diabetes 
Mean age (years): PH2: 11.3; PH3: 12.7; PH4: 13.5; 
PH5: 14.7
Crude and adjusted (for maternal age at  
menarche, maternal age at birth, socioeconomic 
status, cohabitation, parity and maternal BMI)  
mean monthly difference in age (95% CI) at  
Tanner stage PH2, PH3, PH4, PH5
Mean difference (months):
PH2 crude: −1.9; adjusted: −1.4 (−5.3, 2.4);
PH3 crude: −1.9; adjusted: −1.3 (−4.6, 1.9);
PH4 crude: −1.7; adjusted: −0.8 (−3.4, 1.6);
PH crude: −2.6; adjusted: −1.7 (−4.7, 1.3)
 (32) Multistage modelling: 
Median age at transition (95% CI) to >Tanner  
stage PH1, >Tanner stage PH2, >Tanner  
stage PH3
PH>1: GDM was not a covariate in the combined 
multivariate model level due to statistical 
insignificance at the univariate analysis or 
restricted combined model level
PH > 2: In the model with offspring BMI at age 8,
Median age at PH > 2 (years): 12.8 (12.7–12.8)
Median age at PH > 2 among sons of GDM mothers 
(years): 12.6 (12.4–12.7); P = 0.03
In the model with offspring height and weight at age 8,
Median age at PH > 2 (years): 13.0 (12.8–13.1)
Median age at PH > 2 in sons of GDM mothers 
(years): 12.8 (12.6–13.0); P = 0.05
PH > 3: GDM was not a covariate in the combined 
multivariate model level due to statistical 
insignificance at the univariate analysis or 
restricted combined model level
Testicular development
 (27) n (%) of testicular volume ≥4 mL in GDM  
cases and controls
GDM: 143 (74.5%); No GDM: 156 (85.7%)
Age adjusted OR (95% CI) of testicular  
volume ≥4 mL
OR, adjusted: 0.77 (0.42–1.41); P = 0.40
Estimate with additional adjustment for BMI shown 
in primary study’s figure (direction of effect 
remains and still statistically NS)
Genital Development
 (27) n (%) of ≥ Tanner stage G2 in GDM  
cases and controls
GDM: 63 (32.6%); No GDM: 66 (37.5%)
Age adjusted OR (95% CI) of ≥ Tanner stage G2 OR Adjusted: 1.24 (0.72, 2.14); P = 0.45
Estimate with additional adjustment for BMI shown 
in primary study’s figure (Direction of effect 
remains and still statistically NS)
 (31) Mean age at Tanner stage G2, G3, G4, G5  
in sons of mothers without diabetes 
Mean age (years): G2: 10.9; G3: 12.5; G4: 13.6; G5: 15.5
Crude and adjusted (for maternal age at menarche, 
maternal age at birth, socioeconomic status, 
cohabitation, parity and maternal BMI) mean 
monthly difference in age (95% CI) at Tanner  
stage G2, G3, G4, G5
Mean difference (months):
G2: crude: −0.4; adjusted: 0.0 (−3.8, 3.8);
G3: crude: 1.1; adjusted: 1.4 (−1.9, 4.9);
G4: crude: −0.2; adjusted: 0.5 (−2.5, 3.5);
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and PH4 due to statistical insignificance at the predictor 
selection stage of the analysis. In the model predicting 
transition to stage PH3, GDM was included as a predictor 
along with either offspring BMI or height and weight 
anthropometrics measures separately recorded at age 8. In 
the model with BMI, boys born to GDM exposed mothers 
showed 2-month advancement in the age at transition to 
PH3 (Table 3). Median age of transition to PH3 was 12.6 
(95% CI: 12.4, 12.7) for boys born to mothers with GDM 
compared to the entire cohort’s median age of 12.8 (95% 
CI: 12.7, 12.8). In the model with height and weight 
anthropometrics instead of BMI, median age of transition 
to PH3 for boys born to mothers with GDM was 12.8 (95% 
CI: 12.6, 13.0) compared to the entire cohort’s median age 
of transition to PH3 13.0 (95% CI: 12.8, 13.1).
Genital development and testicular volume
Two studies considered the association between maternal 
GDM and the age at onset of male genital development 
(26, 30). Grunnet et al. (26) reported genital stage ≥G2 in 
63 (32.6%) boys of mothers who had GDM and 66 (37.5%) 
boys of mothers without GDM; after adjusting for their 
age, they reported an OR of 1.24 (95% CI: 0.74, 2.14). 
The same study did not report a similar direction of effect 
for gonadarche (testicular volume ≥ 4 mL) in boys born 
to mothers with GDM (adjusted OR: 0.77 (0.42–1.41)) 
(Table 3). Lauridsen et al. (30) did not find any association 
between maternal GDM and the age at genital stages 2–5 
(adjusted mean monthly difference in G2: −0.0 (95% CI: 
−3.8, 3.8); G3: 1.4 (95% CI: −1.9, 4.9); G4: 0.5 (95% CI: 
−2.5, 3.5); G5: 2.6 (95% CI: -2.2, 7.4)) (Table 3).
Age at peak height velocity
Hockett et al. (27) reported age at PHV among boys born 
to mothers with and without GDM as 12.68 and 12.92 
years, respectively, with overlapping confidence intervals. 
Further, they reported a 4% increased PHV among boys 
born to mothers with GDM compared to boys born to 
mothers without GDM after adjusting for race/ethnicity 
(Table 3).
Outcome/study Outcome metrics Estimates
PHV and age at PHV
 (28) Age at PHV stratified by exposure status and β 
coefficient for exposure to GDM in utero after 
adjusting for child’s race/ethnicity 
Age at PHV (years) : GDM: 12.68; No GDM: 12.92
β coefficient and P-value not reported (but figure 
shows overlapping confidence intervals of age at 
PHV between exposed and the unexposed)
PHV among exposed and unexposed girls and boys 
and beta coefficient for exposure to GDM in utero 
after adjusting for child’s race/ethnicity
PHV (cm/year): GDM: 9.65; No GDM: 9.28; 
β coefficient : 0.04; P < 0.001
Spermarche
 (31) Mean age at spermarche in sons of mothers without 
diabetes 
Mean age (years): 13.4
Crude and adjusted (for maternal age at menarche, 
maternal age at birth, socioeconomic status, 
cohabitation, parity and maternal BMI) mean 
monthly difference in age (95% CI) at spermarche
Mean difference (months): crude: 0; adjusted: 0.7 
(−2.9, 4.3)
Other pubertal outcomes
 (31) Mean age at VB, AV, AH, acne in sons of mothers 
without diabetes 
Mean age (years) : VB: 13.0; AV: 15.0; AH: 13.3; Acne: 
12.2
 
Crude and adjusted (for maternal age at menarche, 
maternal age at birth, socioeconomic status, 
cohabitation, parity and maternal BMI) mean 
monthly difference in age (95% CI) at VB, AV, 
development of AH and acne
Mean difference (months): VB: crude: −1.8; adjusted: 
−0.8 (−4.6, 2.8);
AV: crude: −3.2; adjusted: −2.5 (−8.4, 3.4);
AH: crude: −4.3; adjusted: −2.9 (−7.4, 1.8);
Acne: crude: 0.8; adjusted: 1.8 (−2.1, 5.7)
AH, axillary hair; AV, adult voice; HR, hazard ratio; NS, not significant; OR, odds ratio; PHV, peak height velocity; RR, risk ratio; Tanner stage G, Tanner 





















Lauridsen et  al. (30) studied the association between 
maternal GDM and age at first ejaculation. The study 
did not observe any association (adjusted mean monthly 
difference: 0.7 (−2.9, 4.3)) (Table 3).
Discussion
To our knowledge, this is the first systematic review 
that comprehensively explores the relationship between 
maternal GDM and pubertal timing; also stratified by 
offspring gender. Although the current evidence is limited, 
we noted a subtle trend towards earlier pubertal timing in 
children exposed to maternal hyperglycemia manifested 
as GDM in utero. 
We have included studies that report ‘maturational 
events’ that are considered to define puberty, that is, the 
development of secondary sexual characteristics such as 
pubic hair, breast (in girls) and penile growth (in boys), 
growth parameters (such as PHV and age at PHV) and 
critical events, such as menarche and spermarche. 
The point estimates in all the studies are consistent 
with an earlier age at onset of pubarche in both boys 
and girls of mothers with GDM compared to the control 
population. Notably, there was discrepancy in the 
offspring sex-specific effect of maternal GDM on pubarche. 
Specifically, Grunnert et al. (26) suggest more pronounced 
GDM-related odds of pubarche in boys compared to girls 
while Lauridsen et  al. (30) report a more pronounced 
GDM-related precocity of all pubic hair stages in girls 
compared to boys. 
Four studies that examined the onset of breast 
development (26, 28, 29, 30) and two studies that 
examined menarche (25, 30) showed variations in 
the direction, strength and significance of association 
with maternal GDM. The timing of genital growth 
and spermarche did not appear to be affected in boys 
born to mothers with GDM (26, 30). One study did 
collect information on genital development but due to 
invalidation of longitudinal recording indicated by a 
significant proportion of boys proposing Tanner stage 
regression, this outcome was not analysed (31). Growth 
parameters such as PHV and age at PHV in boys and girls 
were associated with maternal GDM (27).
Although the present evidence suggests that maternal 
GDM might be related to early pubertal timing in their 
offspring, this effect is rather modest or not evident in the 
full range of pubertal ‘maturational events’, suggesting a 
complex interplay between GDM and puberty. 
Previous studies have suggested a relationship between 
maternal GDM and offspring adiposity (32). Adiposity and 
‘over-nutrition’ can be considered predictors of pubertal 
timing and principal determinants for the initiation and 
maintenance of pubertal maturational events (33), hence, 
the association between maternal GDM and offspring 
pubertal timing could be mediated by offspring adiposity 
and pre-adolescence BMI. This is supported by the 
analysis by Hockett et al. (27), in which the association 
between maternal GDM and age at PHV is attenuated by 
adjustment for offspring BMI z-score. 
Several studies have suggested a negative association 
between pre-pregnancy BMI and timing of puberty (34, 
35). High pre-pregnancy BMI is an established risk factor 
of GDM (36); however, considering the available studies it 
is difficult to dissect the effects of GDM and pre-pregnancy 
BMI on offspring pubertal timing. Furthermore, an 
U-shaped association between age at menarche and 
future risk of GDM has been established (37). Therefore, 
it is plausible that a synergistic effect exists between the 
intrauterine effect of hyperglycemia on pubertal timing in 
the offspring and the genetic influence of earlier maternal 
age at menarche. In addition to the already explored 
factors adjusted for in various studies, several other factors 
such as birthweight (both higher and lower) (38, 39), 
exogenous exposure to endocrine-disrupting chemicals 
such as phthalates, pesticides and bisphenol A in the 
mother-offspring home environment (40, 41) could have 
confounded this association. The same applies to leptin, 
which largely correlates with body fat content. Higher 
plasma leptin levels have been documented in GDM 
(42) and may contribute to gestational programming 
of offspring obesity as leptin is regarded as a permissive 
signal for puberty initiation (43).
Trends towards earlier pubarche is probably one of 
the most consistent precocities of all puberty parameters 
assessed by the studies analysed in this review. It is 
important to note that the rise of adrenal androgen 
production in late childhood contributes to the 
development of pubic (and axillary) hair, an event known 
as adrenarche (44, 45). Adrenarche is a phenomenon 
currently not well understood, but not related and in fact 
strictly independent of gonadarche. As adrenarche and 
gonadarche frequently overlap, it is clinically not possible 
to distinguish if pubarche is caused by adrenal or testicular 
androgens in boys, however, it is likely that pubic hair 
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in girls. Premature adrenarche has been traditionally 
regarded as benign variant of normal ‘puberty’, however, 
there is some evidence suggesting that children with 
premature adrenarche have metabolic dysfunction, in 
particular abnormal glucose metabolism (46).
To assess the dynamics of pubertal development 
accurately is difficult, both in the individual clinical 
setting but even more so based on observational studies. 
Tanner staging is an unequivocally accepted clinical tool 
to assess pubertal milestones (47), but prone to inter-
observer differences (48, 49) and over/underestimation of 
Tanner staging frequently occurs when being self-reported 
(50). Assessment of the activation of the hypothalamic–
pituitary–gonadal axis via LHRH stimulation testing or 
overnight LH sampling as an outcome measure would aid 
in objectification as well as differentiation of central and 
peripheral causes for advancement in pubertal timing (51, 
52), albeit difficult to perform in larger study populations 
due to invasiveness, logistics and cost implications. Rare 
underlying sinister pathologies, such as sex steroid-
producing tumours or hypothalamic abnormalities, can 
affect pubertal timing, however, were only systematically 
excluded in one of the studies (29). 
The findings of the present review should be 
interpreted in the context of its limitations. One of them 
was the wide variation in the sample sizes of the included 
studies. However, it should be noted that no correlation 
was observed between the sample size and the magnitude 
or significance of effect estimates. Two pairs of derived 
their cohorts from the same databases (26, 28, 29, 30), 
suggesting a possible overlap of the participants between 
these pairs of studies.
The summary measures were widely heterogeneous 
across all of the studies, preventing any meaningful 
attempt to statistically pool the results. The interval 
spanned between subsequent observations of Tanner 
stages or anthropometrics varied across the included 
longitudinal studies, ranging between 6 months and 1.5 
years. Also, there was a high percentage of children who 
did not agree to report their Tanner stage, which could 
bias the effect estimates as previous studies report an 
association between Tanner stage of children and their 
agreement to have it recorded (53). Therefore, interval 
and informative censoring embedded in the observational 
nature of the included studies were potential limitations 
in accurately discerning the association between maternal 
GDM and pubertal timing of children. Lastly, both the 
diagnostic criteria and the approach to testing for GDM 
differ widely by country, from no routine to universal 
screening (54). Routine screening has been recommended 
by the Diabetes in Pregnancy Study Groups (IADPSG) after 
results from the hyperglycaemia and adverse pregnancy 
outcomes (HAPO) study were published in 2008 (55). 
Since screening practices have changed over time with 
a trend to test and diagnose more comprehensively in 
recent years, a shift towards milder GDM phenotypes has 
been observed (56). In the studies included in this review, 
GDM was diagnosed between 1991 and 2006 based on 
different diagnostic criteria (Table 1), and it is possible 
that those differences together with a change of screening 
practices over time contribute to a larger heterogeneity 
in the reported associations with offspring’s pubertal 
outcome measures. 
In order to strengthen the evidence base for the 
association between maternal GDM and pubertal timing, 
large-scale prospective cohort studies should be conducted, 
ideally with standardized approaches in diagnosing GDM 
and recording of wide range of confounders at baseline. 
Future research is needed to understand the biological 
link between the maternal–fetal endocrine system. This 
can help in the identification of potential interventions 
to limit the progression of a potential transgenerational 
continuum of endocrine disturbance and adverse effects 
on metabolic health.
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